Explore methods of reducing cardiovascular risk and aiding weight loss in those with diabetes or at risk for diabetes while reviewing current data on DDP-4 inhibitors and combination therapies.
Contrary to an earlier epidemiological study, rosiglitazone use is not associated with an increased risk of developing cancer, according to a report in the July Diabetes Care. Reuters Health Information
Children and adolescents with type 2 diabetes require individualized management to achieve target levels of glycemic control and thereby minimize risks for hypoglycemia and long-term complications. The Medscape Journal of Medicine
Children and adolescents with type 2 diabetes require individualized management to achieve target levels of glycemic control and thereby minimize risks for hypoglycemia and long-term complications. The Medscape Journal of Medicine
Overweight and obese patients with chronic heart failure (CHF) are at lower risk for death than their normal-weight counterparts, according to results of a meta-analysis of studies that examined the effect of body mass index (BMI) on mortality. Reuters Health Information
Patients with metabolic syndrome are more likely to experience resistance to thrombolysis in middle cerebral artery (MCA) ischemic stroke, according to a report in the July 15th Neurology. Reuters Health Information
Is there value in the early detection of type 2 diabetes? Are there differences between rosiglitazone and pioglitazone? Medscape Diabetes & Endocrinology
Findings from the Canadian Multicentre Osteoporosis Study suggest that repeat measurements of bone density in middle-aged and older adults can be delayed for intervals of up to 5 years in the absence of risk factors for bone loss. Reuters Health Information